vs

Side-by-side financial comparison of HOPE BANCORP INC (HOPE) and MEDIFAST INC (MED). Click either name above to swap in a different company.

HOPE BANCORP INC is the larger business by last-quarter revenue ($141.0M vs $75.1M, roughly 1.9× MEDIFAST INC). On growth, HOPE BANCORP INC posted the faster year-over-year revenue change (21.0% vs -36.9%). Over the past eight quarters, HOPE BANCORP INC's revenue compounded faster (9.8% CAGR vs -34.4%).

Bank of Hope is an American bank, based in Los Angeles, that focuses on the Korean American community. The bank was first established on December 30, 1980, under the name Wilshire Bank.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

HOPE vs MED — Head-to-Head

Bigger by revenue
HOPE
HOPE
1.9× larger
HOPE
$141.0M
$75.1M
MED
Growing faster (revenue YoY)
HOPE
HOPE
+57.9% gap
HOPE
21.0%
-36.9%
MED
Faster 2-yr revenue CAGR
HOPE
HOPE
Annualised
HOPE
9.8%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
HOPE
HOPE
MED
MED
Revenue
$141.0M
$75.1M
Net Profit
$29.5M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
20.9%
Revenue YoY
21.0%
-36.9%
Net Profit YoY
EPS (diluted)
$0.23
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HOPE
HOPE
MED
MED
Q1 26
$141.0M
Q4 25
$145.8M
$75.1M
Q3 25
$141.9M
$89.4M
Q2 25
$94.5M
$105.6M
Q1 25
$116.5M
$115.7M
Q4 24
$118.0M
$119.0M
Q3 24
$116.6M
$140.2M
Q2 24
$116.9M
$168.6M
Net Profit
HOPE
HOPE
MED
MED
Q1 26
$29.5M
Q4 25
Q3 25
$30.8M
$-2.3M
Q2 25
$-24.8M
$2.5M
Q1 25
$21.1M
$-772.0K
Q4 24
Q3 24
$24.2M
$1.1M
Q2 24
$25.3M
$-8.2M
Gross Margin
HOPE
HOPE
MED
MED
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
HOPE
HOPE
MED
MED
Q1 26
Q4 25
26.8%
-10.4%
Q3 25
25.6%
-4.6%
Q2 25
-27.6%
-1.0%
Q1 25
23.9%
-1.1%
Q4 24
25.8%
0.6%
Q3 24
27.5%
1.5%
Q2 24
29.5%
-4.7%
Net Margin
HOPE
HOPE
MED
MED
Q1 26
20.9%
Q4 25
Q3 25
21.7%
-2.5%
Q2 25
-26.2%
2.3%
Q1 25
18.1%
-0.7%
Q4 24
Q3 24
20.7%
0.8%
Q2 24
21.6%
-4.8%
EPS (diluted)
HOPE
HOPE
MED
MED
Q1 26
$0.23
Q4 25
$0.27
$-1.64
Q3 25
$0.24
$-0.21
Q2 25
$-0.19
$0.22
Q1 25
$0.17
$-0.07
Q4 24
$0.20
$0.08
Q3 24
$0.20
$0.10
Q2 24
$0.21
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HOPE
HOPE
MED
MED
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$198.9M
Total Assets
$18.7B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HOPE
HOPE
MED
MED
Q1 26
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Stockholders' Equity
HOPE
HOPE
MED
MED
Q1 26
$2.3B
Q4 25
$2.3B
$198.9M
Q3 25
$2.3B
$214.7M
Q2 25
$2.2B
$216.0M
Q1 25
$2.2B
$211.0M
Q4 24
$2.1B
$210.1M
Q3 24
$2.2B
$207.3M
Q2 24
$2.1B
$205.3M
Total Assets
HOPE
HOPE
MED
MED
Q1 26
$18.7B
Q4 25
$18.5B
$248.0M
Q3 25
$18.5B
$268.2M
Q2 25
$18.5B
$269.3M
Q1 25
$17.1B
$280.0M
Q4 24
$17.1B
$284.2M
Q3 24
$17.4B
$291.2M
Q2 24
$17.4B
$293.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HOPE
HOPE
MED
MED
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HOPE
HOPE
MED
MED
Q1 26
Q4 25
$164.5M
$-5.3M
Q3 25
$51.7M
$12.1M
Q2 25
$9.4M
$-3.4M
Q1 25
$26.7M
$3.4M
Q4 24
$116.7M
$-4.9M
Q3 24
$63.0M
$9.1M
Q2 24
$-25.6M
$13.1M
Free Cash Flow
HOPE
HOPE
MED
MED
Q1 26
Q4 25
$151.5M
$-6.6M
Q3 25
$47.2M
$10.8M
Q2 25
$6.9M
$-4.8M
Q1 25
$24.0M
$1.9M
Q4 24
$106.9M
$-7.2M
Q3 24
$60.1M
$7.7M
Q2 24
$-28.1M
$11.1M
FCF Margin
HOPE
HOPE
MED
MED
Q1 26
Q4 25
103.9%
-8.8%
Q3 25
33.2%
12.0%
Q2 25
7.3%
-4.5%
Q1 25
20.6%
1.6%
Q4 24
90.6%
-6.1%
Q3 24
51.6%
5.5%
Q2 24
-24.0%
6.6%
Capex Intensity
HOPE
HOPE
MED
MED
Q1 26
Q4 25
9.0%
1.8%
Q3 25
3.2%
1.5%
Q2 25
2.6%
1.3%
Q1 25
2.3%
1.3%
Q4 24
8.3%
1.9%
Q3 24
2.5%
1.0%
Q2 24
2.2%
1.1%
Cash Conversion
HOPE
HOPE
MED
MED
Q1 26
Q4 25
Q3 25
1.68×
Q2 25
-1.36×
Q1 25
1.26×
Q4 24
Q3 24
2.61×
8.04×
Q2 24
-1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons